Revoked by Donald Trump on January 20, 2025
Ordered by Joseph R. Biden Jr. on January 27, 2021
President Biden established an advisory council (PCAST) to provide scientific and technological expertise from non-governmental experts for policy decisions on issues including health, energy, security, and equity. Revoked by President Trump, the EO's termination ended formal advisory input from independent scientific experts to the White House.
Before its revocation, Executive Order 14007 significantly contributed to aligning federal science and technology initiatives with evidence-based policymaking. The establishment of the President's Council of Advisors on Science and Technology (PCAST) through this order reinforced a commitment to integrating scientific expertise into policymaking processes. This integration facilitated the timely incorporation of expert insights into decisions spanning diverse sectors, including energy, education, and public health. By consulting with a broad spectrum of stakeholders, from national laboratories to nonprofit organizations, PCAST elevated the role of scientific advice in crafting policies that affected millions of Americans. More than just a group of advisors, it represented a structural effort to reduce the disconnect between scientific research and policy enactment.
Operational adjustments were made across executive departments and agencies to accommodate the council's directives, especially concerning data sharing and interagency collaboration. For instance, the Department of Energy was tasked with providing technical and financial support, reflecting a concerted effort to dissolve silos within federal operations. This enhanced interagency cooperation not only streamlined processes surrounding scientific advice but also reinforced the council's recommendations in practice. As a result, agencies were more able to respond to emerging scientific challenges, such as climate change and public health threats, with cohesive strategies rooted in shared knowledge.
In terms of specific agency directives without formal rulemaking, scientific integrity protocols were reinforced, ensuring that policymaking remained insulated from political pressures. An extension of these protocols was evident in the proactive solicitation of diverse perspectives from sectors outside the federal government. Inclusion of non-federal experts, ranging from university researchers to private sector leaders, ensured that the council's recommendations were well-rounded and reflective of cutting-edge developments in science and technology. Thus, it enforced a broader cultural shift towards valuing scientific rigor and input in policy formulation, a notable departure from periods where science advisory panels faced underutilization or neglect.
The revocation of this executive order by President Donald Trump on January 20, 2025, appears to fit into a broader ideological realignment emphasizing deregulation, skepticism towards centralized expertise, and a preference for industry-led innovation. This ideological shift marked a pivot away from the Biden administration’s reliance on formal scientific advisory structures, reflecting a belief that such entities may encumber swift policy shifts with exhaustive deliberations. By dismantling PCAST, Trump's administration effectively signaled a reduction in the formalized involvement of external scientific bodies in directing policy narratives.
Revocation may also represent a strategic realignment emphasizing streamlined executive decision-making processes in science and technology policy. Such a shift could facilitate more flexible, albeit centralized, decision-making pathways, free from the constraints of advisory council deliberations. This approach favors the executive branch’s direct interactions with industry leaders, weighting commercial imperatives as equally indispensable as scientific insight, if not more so. This prioritization of industry could indicate an ideological stance favoring the perception of science as a component of economic strategy, rather than a guiding force in policy itself.
Broader political motivations could also underlie this move, aligning with Trump’s previous administration’s hallmark approach of cutting through advisory and bureaucratic layers to favor direct engagement with stakeholders like industry leaders and political allies. Such an alignment facilitates rapid enactment of policies reflective of his administration's economic and ideological priorities, potentially perceived as cumbersome under the advisory framework encouraged by Biden’s provisions. This strategy reflects an overarching philosophy of governance characterized by transactional engagement over collective deliberation.
The revocation appears to run parallel with broader moves to decentralize federal control over science-rooted policies—giving greater voice to state and private institutions. This might suggest a view that state governments and private enterprises possess sufficient capacity for regulating local scientific concerns without overarching federal oversight. Underlying this refocusing effort is a potential ideological belief in minimizing federal overreach—considered by some constituencies as stifling innovation—and propagating that responsibility, wherein necessary, to market dynamics and state initiatives.
Corporations with significant vested interests in deregulation emerged as likely beneficiaries of this revocation, particularly those within technology and energy sectors seeking expedited project approvals without cumbersome federal oversight. Without the structured input of PCAST, industries may find greater leeway to advocate for policy changes that prioritize economic growth over cautionary scientific advisories, simplifying pathways for new technologies and innovations to reach the market rapidly. The resulting regulatory flexibility benefits those sectors accustomed to demonstrating innovation without extensive pre-market evaluations.
Similarly, states advocating for increased autonomy in policy implementation have much to gain from this policy shift. Reducing the federal emphasis on advisory councils redistributes policy-enacting leverage closer to state leadership, empowering governors and local lawmakers. States that have developed robust local advisory and regulatory bodies may capitalize on this transition to align environmental and technological policies closer to regional economic goals rather than centralized scientific assessments, potentially expediting growth in locally-dominant industries.
Political allies favoring federal decentralization are also poised to benefit. As policy formation continues to lean towards individual executive engagement rather than multi-faceted advisories, lobbyists employed by enterprises aligned with Trump’s vision gain stronger footholds in advocacy endeavors. The revocation thus effectively empowers sectors within the political establishment seeking quicker transitions through reduced federal oversight across policy enactments rooted in science and technology.
Research institutions and scholars stand among the most immediate losers. With the dismantling of formalized avenues for input into federal policy, these bodies might face diminished opportunities for ensuring that scientific rigor informs legislative and executive decisions. As the apparatus facilitating dialogue between research bodies and policymakers, PCAST's absence potentially silences voices that advocate for long-term solutions predicated on established scientific methodologies rather than immediate economic concerns.
Furthermore, environmental groups face potential setbacks as the balance tilts away from science-first advisory frameworks towards economic imperatives, potentially compromising efforts to foreground sustainable practices in policy discussions. Without a dedicated science advisory council fostering environmental sustainability, advocates and organizations dedicated to climate or environmental protection might find it increasingly challenging to introduce scientific evidence into policy decisions dominated by economic growth interests.
Finally, public sector employees engaged in implementing science-driven policies might experience uncertainty or reduced influence within their roles. As PCAST previously facilitated cross-sectoral cohesion among federal initiatives, its removal may lead to fragmented policy interpretation and implementation. Without direct access to multidisciplinary advisory mechanisms, federal employees could encounter challenges in maintaining coherence across science-driven initiatives, possibly impacting their effectiveness in executing policy interventions addressing nationwide scientific concerns.
Users with accounts see get different text depending on what type of user they are. General interest, journalist, policymaker, agency staff, interest groups, litigators, researches.
Users will be able to refine their interests so they can quickly see what matters to them.